Swalife Healthcare Consultancy helps healthcare innovators connect evidence, scientific communication and product development—so the next decision is clearer, better documented and less dependent on guesswork.
Start with one blocked decision or engage us across the full research-to-market journey.
Organize evidence into rigorous, decision-useful scientific communication.
Translate clinical, safety and regulatory information for the right audience.
Build a defensible route from product opportunity to validation and documentation.
The scientific questions are shared; the formulation, testing and claims realities are sector-specific.
Serums, creams, gels, cleansers, masks and botanical actives—aligned to skin concern, delivery, compatibility, stability, safety and claim strategy.
Scalp products, oils, serums, shampoos and conditioners—built around target, ingredient rationale, sensorial performance and substantiated communication.
Powders, capsules, tablets, liquids and combinations—considering identity, dose rationale, interactions, quality, evidence and consumer use.
Single botanicals, combinations and extracts—addressing botanical identity, standardization, phytochemistry, formulation, quality, safety and evidence gaps.
Each stage resolves a defined question before more time or budget is committed.
Define the product, user, need, target market and blocked decision.
Review evidence, ingredients, competitors, safety, claims and gaps.
Create the concept, Target Product Profile and development plan.
Develop or refine prototypes, ingredient roles and process choices.
Plan or review quality, stability, safety and performance testing.
Build technical, scientific, claims and partner-ready documentation.
Recommend go, revise, validate further, partner or stop.
Assist transfer, launch preparation and post-development learning.
Scope, timeline and fees are confirmed after a brief project assessment.
A rapid screen of evidence, differentiation, risk flags, gaps and recommended next step.
Integrated evidence, formulation, safety, claims, IP and development planning.
A focused recommendation, rationale, workplan and stakeholder readout.
A defined document, evidence strategy, review cycle and final editable deliverable.
Scheduled technical reviews, decision notes and priorities across a programme or portfolio.
Yes. An engagement can address one defined question—such as evidence review, writing, formulation strategy or validation planning—or connect several stages.
Only when they are expressly included in the written scope or coordinated through an agreed qualified partner. Third-party costs are quoted separately.
No. The consultancy improves evidence, documentation and decision quality; it cannot guarantee external decisions or commercial outcomes.
The product or research objective, target user and market, current development stage, available data, constraints and the specific decision you need to make.